Kinase Inhibitors

IDH2R140Q-IN-2 View larger

IDH2R140Q-IN-2

AT79745

CAS 2749568-16-7

More details

Molarity Calculation Cart®

HOW TO ORDER

$337.00

$337.00 per mg

Quantity Discount Table - Order More To Get More Price Discount

QuantitymgUnit Price ($/mg or $/Unit)Final Price
1100 $151.65 Total: $15,165.00
150 $175.24 Total: $8,762.00
125 $205.57 Total: $5,139.25
110 $242.64 Total: $2,426.40
15 $286.45 Total: $1,432.25

Data sheet

Molecular FormulaC21H18F6N6O
Molecular Weight484.4
CAS Numbers2749568-16-7
Storage Condition0C Short Term, -20C Long Term
SolubilityDMSO
Purity98% by HPLC
SMILES CodeFC(F)(F)C=1C=CC=C(C1)NC=2N=C(N=C(N2)N3CCC(O)C3)NC4=CC=CC(=C4)C(F)(F)F
ReferencesWei Q, et al. Structure-Based Drug Design of Novel Triaminotriazine Derivatives as Orally Bioavailable IDH2R140Q Inhibitors with High Selectivity and Reduced hERG Inhibitory Activity for the Treatment of Acute Myeloid Leukemia. J Med Chem. 2023 Sep 28;66[18] 12894-12910.

More info

IDH2R140Q-IN-2 is an orally active and potent IDH2R140Q inhibitor with an IC50 of 29 nM.IDH2R140Q-IN-2 possesses potential antitumour activity, reducing D2HG production in TF-1 cell lines carrying the IDH2R140Q mutation (IC50 of 10 nM) and inhibiting tumour tissue D2HG levels.IDH2R140Q-IN-2 is suitable for the study of acute myeloid leukaemia (AML).